While tumor necrosis factor a inhibition (TNFi) was considered, given the possibility of systemic lupus erythematosus features in MCTD, we did not want to risk drug-induced lupus symptoms from a TNFi therapy. Here, TNF is linked to systemic lupus erythematosus.